Sphere Fluidics' Grant

Sphere Fluidics raised a round of funding on November 27, 2017. Investors include Eurostars Programme.

Spher Fluidics provides Cyto-Mine technology, an integrated device that uses picodroplet technology and microfluidics to process around 1 million heterogeneous mammalian cells in less than half a day.…

Articles about Sphere Fluidics' Grant: